Mirae Asset Global Investments’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Sell
4,812
-783
-14% -$27K ﹤0.01% 1122
2026
Q1
$176K Buy
5,595
+450
+9% +$13K ﹤0.01% 1086
2025
Q4
$128K Buy
5,145
+1,072
+26% +$21.5K ﹤0.01% 1215
2025
Q3
$66.1K Buy
4,073
+11
+0.3% +$156 ﹤0.01% 1297
2025
Q2
$53.3K Buy
4,062
+894
+28% +$12.9K ﹤0.01% 1247
2025
Q1
$73.7K Buy
3,168
+13
+0.4% +$341 ﹤0.01% 1167
2024
Q4
$90.7K Sell
3,155
-237
-7% -$7.55K ﹤0.01% 1163
2024
Q3
$88.5K Buy
3,392
+604
+22% +$12K ﹤0.01% 1204
2024
Q2
$48.8K Sell
2,788
-14,533
-84% -$253K ﹤0.01% 1255
2024
Q1
$152K Sell
17,321
-3,512
-17% -$55.8K ﹤0.01% 2313
2023
Q4
$228K Buy
20,833
+4,785
+30% +$33.6K ﹤0.01% 2295
2023
Q3
$92K Buy
16,048
+60
+0.4% +$408 ﹤0.01% 2473
2023
Q2
$124K Sell
15,988
-129
-0.8% -$1.09K ﹤0.01% 2458
2023
Q1
$108K Sell
16,117
-40
-0.2% -$371 ﹤0.01% 2435
2022
Q4
$144K Buy
16,157
+357
+2% +$3.35K ﹤0.01% 2381
2022
Q3
$155K Buy
15,800
+3,719
+31% +$37.6K ﹤0.01% 2414
2022
Q2
$96K Buy
+12,081
New +$91.3K ﹤0.01% 2309

Other funds holding EWTX

Mirae Asset Global Investments's EWTX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Edgewise Therapeutics (EWTX) stake by 14% in Q2 2026, selling an estimated $27K and leaving 4,812 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Mirae Asset Global Investments first reported a position in EWTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $228K in Q4 2023. 65 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Mirae Asset Global Investments held 4,812 shares of Edgewise Therapeutics worth $196K as of Q2 2026.
  • Mirae Asset Global Investments sold 783 Edgewise Therapeutics shares in Q2 2026, an estimated $27K.
  • Edgewise Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1122 holding.
  • Mirae Asset Global Investments first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Edgewise Therapeutics position peaked at $228K in Q4 2023.
  • 65 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.